VERTEX PHARMACEUTICALS INC / MA Noncash or Part Noncash Acquisition, Fixed Assets Acquired
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2021-02-11
- VERTEX PHARMACEUTICALS INC / MA noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2019-12-31 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2019-09-30 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA noncash or part noncash acquisition, fixed assets acquired for fiscal 2020 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA noncash or part noncash acquisition, fixed assets acquired for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- VERTEX PHARMACEUTICALS INC / MA noncash or part noncash acquisition, fixed assets acquired for fiscal 2018 was $3.39M, a 91.70% decline from fiscal 2017.
- VERTEX PHARMACEUTICALS INC / MA noncash or part noncash acquisition, fixed assets acquired for fiscal 2017 was $40.85M, a 186.94% increase from fiscal 2016.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-11 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $0.00 derived: sum of 2 quarters · filed 2021-02-11 | $0.00 derived: sum of 3 quarters · filed 2021-02-11 | $0.00 10-K · filed 2021-02-11 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | $0.00 derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | $0.00 derived: sum of 3 quarters · filed 2021-02-11 | -$1.79M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-01 | $0.00 derived: sum of 2 quarters · filed 2021-02-11 | -$1.79M derived: sum of 3 quarters · filed 2021-02-11 | -$327.00K derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$1.79M derived: sum of 2 quarters · filed 2021-02-11 | -$327.00K derived: sum of 3 quarters · filed 2021-02-11 | $3.39M 10-K · filed 2021-02-11 |
| 2018-09-30 | -$1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$327.00K derived: sum of 2 quarters · filed 2019-10-31 | $3.39M 10-Q · filed 2019-10-31 | $10.42M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $5.18M 10-Q · filed 2019-08-01 | $12.20M derived: sum of 3 quarters · filed 2020-02-13 | $7.10M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $3.72M 10-Q · filed 2019-05-01 | $10.74M derived: sum of 2 quarters · filed 2020-02-13 | $5.64M derived: sum of 3 quarters · filed 2020-02-13 | $32.02M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $7.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $1.93M derived: sum of 2 quarters · filed 2020-02-13 | $28.31M derived: sum of 3 quarters · filed 2020-02-13 | $40.85M 10-K · filed 2020-02-13 |
| 2017-09-30 | -$5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $21.28M derived: sum of 2 quarters · filed 2018-10-25 | $33.83M 10-Q · filed 2018-10-25 | $47.24M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-06-30 | $26.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $38.93M 10-Q · filed 2018-07-26 | $52.34M derived: sum of 3 quarters · filed 2019-02-13 | $53.17M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-03-31 | $12.55M 10-Q · filed 2018-04-27 | $25.96M derived: sum of 2 quarters · filed 2019-02-13 | $26.79M derived: sum of 3 quarters · filed 2019-02-13 | $26.79M derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | $13.41M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $14.24M derived: sum of 2 quarters · filed 2019-02-13 | $14.24M derived: sum of 3 quarters · filed 2019-02-13 | $14.24M 10-K · filed 2019-02-13 |
| 2016-09-30 | $824.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $824.00K derived: sum of 2 quarters · filed 2017-10-30 | $824.00K 10-Q · filed 2017-10-30 | $824.00K derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $0.00 10-Q · filed 2017-07-28 | $0.00 derived: sum of 3 quarters · filed 2018-02-15 | $0.00 derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $0.00 10-Q · filed 2017-04-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-15 | $0.00 derived: sum of 3 quarters · filed 2018-02-15 | $0.00 derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $0.00 derived: sum of 2 quarters · filed 2018-02-15 | $0.00 derived: sum of 3 quarters · filed 2018-02-15 | $0.00 10-K · filed 2018-02-15 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $0.00 derived: sum of 2 quarters · filed 2016-10-31 | $0.00 10-Q · filed 2016-10-31 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $0.00 10-Q · filed 2015-08-04 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-04 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $25.56M 10-K · filed 2017-02-23 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $0.00 derived: sum of 2 quarters · filed 2015-10-30 | $25.56M 10-Q · filed 2015-10-30 | $64.09M derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $25.56M 10-Q · filed 2015-08-04 | $64.09M derived: sum of 3 quarters · filed 2016-02-16 | $110.36M derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-03-31 | $25.56M 10-Q · filed 2015-05-04 | $64.09M derived: sum of 2 quarters · filed 2016-02-16 | $110.36M derived: sum of 3 quarters · filed 2016-02-16 | $174.53M derived: sum of 4 quarters · filed 2016-02-16 |
| 2013-12-31 | $38.53M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | $84.79M derived: sum of 2 quarters · filed 2016-02-16 | $148.96M derived: sum of 3 quarters · filed 2016-02-16 | $215.01M 10-K · filed 2016-02-16 |
| 2013-09-30 | $46.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $110.43M derived: sum of 2 quarters · filed 2014-11-06 | $176.48M 10-Q · filed 2014-11-06 | $244.08M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | $64.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $130.22M 10-Q · filed 2014-07-31 | $197.82M derived: sum of 3 quarters · filed 2015-02-13 | $261.48M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | $66.05M 10-Q · filed 2014-05-05 | $133.65M derived: sum of 2 quarters · filed 2015-02-13 | $197.31M derived: sum of 3 quarters · filed 2015-02-13 | $263.42M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | $67.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $131.25M derived: sum of 2 quarters · filed 2015-02-13 | $197.37M derived: sum of 3 quarters · filed 2015-02-13 | $235.59M 10-K · filed 2015-02-13 |
| 2012-09-30 | $63.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $129.77M derived: sum of 2 quarters · filed 2013-11-07 | $168.00M 10-Q · filed 2013-11-07 | $198.47M derived: sum of 4 quarters · filed 2014-02-11 |
| 2012-06-30 | $66.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $104.34M 10-Q · filed 2013-08-02 | $134.82M derived: sum of 3 quarters · filed 2014-02-11 | $149.11M derived: sum of 4 quarters · filed 2014-02-11 |
| 2012-03-31 | $38.23M 10-Q · filed 2013-05-08 | $68.70M derived: sum of 2 quarters · filed 2014-02-11 | $83.00M derived: sum of 3 quarters · filed 2014-02-11 | |
| 2011-12-31 | $30.48M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $44.77M derived: sum of 2 quarters · filed 2014-02-11 | $54.66M 10-K · filed 2014-02-11 | |
| 2011-09-30 | $14.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $24.18M 10-Q · filed 2012-11-06 | ||
| 2011-06-30 | $9.89M 10-Q · filed 2012-08-08 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |